NCT00775099

Brief Summary

Air pollution is a major cause of cardiovascular morbidity and mortality. The components of air pollution responsible and the mechanisms through which they might mediate these harmful effects remain only partially understood. The link between cardiovascular disease and air pollution is strongest for fine particulate matter. Fine particulate matter (PM) is produced from the combustion of fossil fuels with the most significant threat thought to be posed by small particles less than 10µm (PM 10) which can be inhaled into the lungs. We propose to identify the precise component of diesel exhaust that mediates the adverse cardiovascular effects using a carbon particle generator, and a particle concentrator. The aim of this study proposal is to assess the vascular effects of different types and components of air pollution in healthy subjects. We intend to test the hypotheses that:

  1. 1.Combustion derived nanoparticulate causes an acute impairment of endothelial vasomotor and fibrinolytic function in healthy volunteers.
  2. 2.Exposure to combustion derived air pollution is associated with increased thrombus formation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2005

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2005

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2006

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

October 16, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 17, 2008

Completed
Last Updated

October 17, 2008

Status Verified

October 1, 2008

Enrollment Period

6 months

First QC Date

October 16, 2008

Last Update Submit

October 16, 2008

Conditions

Keywords

Air PollutionParticlesParticulate MatterVascular functionEndothelial functionThrombosis

Outcome Measures

Primary Outcomes (1)

  • Forearm blood flow measured by forearm venous occlusion plethysmography in response to infused vasodilators

    6-8 hours after exposure

Secondary Outcomes (7)

  • Ex-vivo thrombus formation assessed using the Badimon chamber

    6 hours after exposure

  • Arterial stiffness measured by radial artery tonometry

    Before and after exposure

  • Heart rate and heart rate variability measured with 3 lead Holter electrographic monitors

    During and for 24 hours after exposure

  • Blood pressure

    During and after exposure and during forearm study

  • Plasma t-PA and PAI concentrations following infusion of bradykinin

    During forearm study

  • +2 more secondary outcomes

Study Arms (4)

Filtered Air Exposure

EXPERIMENTAL

1 hour exposure to filtered air during intermittent exercise

Procedure: Forearm Vascular StudyProcedure: Badimon Chamber

Diesel Exhaust Exposure

EXPERIMENTAL

1 hour exposure to dilute diesel exhaust at a concentration of 300 µg/m3 during intermittent exercise

Procedure: Forearm Vascular StudyProcedure: Badimon Chamber

Filtered Diesel Exposure

EXPERIMENTAL

1 hour exposure to diesel exhaust with all particulates filtered out using teflon filter with intermittent exercise

Procedure: Forearm Vascular StudyProcedure: Badimon Chamber

PALAS Exposure

EXPERIMENTAL

1 hour exposure to pure carbon particles produced by PALAS generator during intermittent exercise

Procedure: Forearm Vascular StudyProcedure: Badimon Chamber

Interventions

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 mg/min).

Also known as: BK, SNP, ACh
Diesel Exhaust ExposureFiltered Air ExposureFiltered Diesel ExposurePALAS Exposure

Ex-vivo assessment of thrombus formation using Badimon Chamber

Diesel Exhaust ExposureFiltered Air ExposureFiltered Diesel ExposurePALAS Exposure

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers

You may not qualify if:

  • Current smokers
  • Significant occupational exposure to air pollution
  • History of lung disease
  • Women of child-bearing potential
  • Malignant arrhythmias
  • Renal or hepatic failure
  • Significant co-morbidity
  • Systolic blood pressure \>190 or \<100 mmHg
  • Previous history of blood dyscrasia
  • Unable to tolerate the supine position
  • Lack of informed consent
  • Blood donation within last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Edinburgh

Edinburgh, EH16 4SB, United Kingdom

Location

Related Publications (2)

  • Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005 Dec 20;112(25):3930-6. doi: 10.1161/CIRCULATIONAHA.105.588962.

    PMID: 16365212BACKGROUND
  • Langrish JP, Watts SJ, Hunter AJ, Shah AS, Bosson JA, Unosson J, Barath S, Lundback M, Cassee FR, Donaldson K, Sandstrom T, Blomberg A, Newby DE, Mills NL. Controlled exposures to air pollutants and risk of cardiac arrhythmia. Environ Health Perspect. 2014 Jul;122(7):747-53. doi: 10.1289/ehp.1307337. Epub 2014 Mar 25.

MeSH Terms

Conditions

Thrombosis

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Nicholas L Mills, MB BCh MRCP

    University of Edinburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 16, 2008

First Posted

October 17, 2008

Study Start

September 1, 2005

Primary Completion

March 1, 2006

Study Completion

March 1, 2006

Last Updated

October 17, 2008

Record last verified: 2008-10

Locations